Loading...
Derniers dépôts
-
-
-
-
-
Francesco Galli, Laricia Bragg, Maira Rossi, Daisy Proietti, Laura Perani, et al.. Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy. EMBO Molecular Medicine, 2024, 16 (4), pp.927 - 944. ⟨10.1038/s44321-024-00031-3⟩. ⟨hal-04603972⟩
-
-
-
Julia Pereira Lemos, Liliane Patrícia Gonçalves Tenório, Vincent Mouly, Gillian Butler-Browne, Daniella Arêas Mendes-Da-Cruz, et al.. T cell biology in neuromuscular disorders: a focus on Duchenne Muscular Dystrophy and Amyotrophic Lateral Sclerosis. Frontiers in Immunology, 2023, 14, pp.120283. ⟨10.3389/fimmu.2023.1202834⟩. ⟨hal-04603915⟩
-
-
-
-
Angelos Gerassimopoulos, Céline Michaud, Mélanie Gaillet, Cyril Rousseau, Adriana Gonzalez, et al.. Santé et recours aux soins et à la prévention des travailleuses du sexe dominicaines vivant le long du fleuve Maroni. 6e journées des travaux scientifiques des soignant.e.s de Guyane, May 2023, Cayenne, Guyane française. ⟨hal-04585175⟩
-
Joe-Elie Salem, Marie Bretagne, Baptiste Abbar, Sarah Leonard-Louis, Stéphane Ederhy, et al.. Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis. Cancer Discovery, 2023, 13 (5), pp.1100-1115. ⟨10.1158/2159-8290.CD-22-1180⟩. ⟨hal-04578810⟩
-
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Vanessa Ueberschlag-Pitiot, Amalia Stantzou, Julien Messéant, Megane Lemaitre, Daniel Owens, et al.. Gonad-related factors promote muscle performance gain during postnatal development in male and female mice. AJP - Endocrinology and Metabolism, 2017, 313 (1), pp.E12-E25. ⟨10.1152/ajpendo.00446.2016⟩. ⟨hal-03677800⟩
-
-
-
Hubert Smeets, Bram Verbrugge, Xavier Bulbena, Liliya Hristova, Julia Vogt, et al.. European Joint Programme on Rare Diseases workshop: LAMA2-muscular dystrophy: paving the road to therapy March 17–19, 2023, Barcelona, Spain. LAMA2-muscular dystrophy: paving the road to therapy, Neuromuscular Disorders, 36, pp.16 - 22, 2024, ⟨10.1016/j.nmd.2024.01.001⟩. ⟨hal-04546346⟩
-
Nombre de documents
790
Nombre de notices
1 381
widget_cloud
Mechanotransduction
Lamin A/C LMNA gene
Male
Clinical trials
Treatment
Calcium
CTG repeat contractions
Congenital muscular dystrophy
Rare neuromuscular diseases
Antisense oligonucleotides
Trinucleotide repeat expansion
OPMD
Myotonic dystrophy
Myopathies
Brain
Alternative splicing
Cytokines
Myasthenia gravis
Heart failure
Cytoskeleton
DMD
Neuromuscular disease
Satellite cell
Becker muscular dystrophy
Dermatomyositis
ALS
Muscle
Amyotrophic lateral sclerosis
Exercise
Glutamate
AAV
Inflammation
Nuclear envelope
Humans
Skeletal muscle
Genotype phenotype correlation
Myotonic Dystrophy
Fibrosis
LMNA
Cardiomyopathy
Myoblasts
Autoantibodies
CRISPRi
Lamin A/C
Myasthenia Gravis MG
Motoneuron
PABPN1
Myositis
Laminopathy
FSHD
Long read sequencing
Dynamin 2
Neuromuscular junction
Muscular dystrophy
Cancer
Dilated cardiomyopathy
Regeneration
Outcome measures
Dystrophin
Oxidative stress
Mouse model
Biomarkers
Cell therapy
Transcriptomics
Biomarker
Congenital myopathy
RNA biology
Heart
MBNL
Gene therapy
Neuromuscular diseases
RNA interference
Fabry disease
Rare diseases
Laminopathie
Myogenesis
Animals
Astrocyte
Actin
Laminopathies
Transgenic mouse model
Myotonic Dystrophy type 1
COVID-19
CMS
Aged
Autophagy
Myopathy
Satellite cells
Autoimmunity
Therapy
Aging
Errance diagnostique
Duchenne muscular dystrophy
Myotonic dystrophy type 1
Centronuclear myopathy
LMNA gene
Autoimmune diseases
Muscle regeneration
Thymus
Thérapie génique